Alterity Therapeutics (ATH) Stock Price, News & Analysis

Company Overview

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $54.91 million
• P/E Ratio: N/A
• Dividend Yield: 5.02%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: ASX:ATH
• CIK: N/A
• Web: alteritytherapeutics.com
• Phone: 61 3 9349 4906
• Fax: N/A
• Employees: 11
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-19,120,000.00
• Net Margins: -475.79%
• Pretax Margin: N/A
• Return on Equity: -121.72%
• Return on Assets: -52.66%

Debt

• Debt-to-Equity Ratio: 1.15
• Current Ratio: 3.54
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $4.02 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,250,000,000
• Free Float: N/A
• Market Cap: $54.91 million
• Optionable: Not Optionable
• Beta: 0.68